Famotydyna Ranigast 20 mg x 20 tabl. powl.

How to use: Use as directed by your doctor
Detailed instructions for use can be found in the leaflet included in the package.

Storage: Store at ambient temperature

Famotidine

Zakłady Farmaceutyczne Polpharma S.A.

Zakłady Farmaceutyczne Polpharma S.A.,
street Pelplińska 19,
83-200 Starogard Gdański,
EN

Treatment with histamine H2 receptor antagonists, including but not limited to: famotidine, may mask the symptoms of stomach cancer and delay proper diagnosis. If you experience any disturbing symptoms (e.g. recurrent vomiting, hematemesis or melaena), you should contact your doctor to rule out the presence of cancer. It is also recommended that the following patients seek medical advice before taking Famotidine Ranigast: middle-aged or elderly patients with symptoms of indigestion that have appeared for the first time or have recently changed; patients with difficulty swallowing, long-term abdominal pain or unintentional weight loss combined with symptoms of indigestion. If the symptoms do not subside after 14 days of treatment,the diagnosis should be verified immediately. Famotidine is excreted mainly by the kidneys, which may lead to an increase in its concentration in blood serum in patients with renal impairment. Famotidine is not suitable for patients with renal impairment who are not under medical care. Famotidine is contraindicated for use in patients with renal failure. The safety and effectiveness of the product in children have not been studied. When famotidine was administered to elderly patients during clinical trials, no increase in the incidence or change in the type of drug-related adverse events was observed. No dose adjustment is required just because of age. Due to the content of cochineal red, the product may cause allergic reactions.